NCT06708910View on ClinicalTrials.gov

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

RecruitingOBSERVATIONAL

Enrollment

460

Participants

Timeline

Start Date

July 18, 2025

Primary Completion Date

March 31, 2031

Study Completion Date

July 31, 2031

Conditions

HER2 Positive Breast Carcinoma

Trial Locations (1)

40225

RECRUITING

Department of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf

All Listed Sponsors

collaborator

University Hospital, Essen

OTHER

collaborator

Marienhospital Bottrop

UNKNOWN

lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT06708910 - AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI | Biotech Hunter | Biotech Hunter